Thanks Iron pig,
Yes, ATH434 also showed positive effects in preventing oxidative effects, by clearing excess iron, thus reducing neuron damage.
There are a number of readings supporting ATH434 in many different factors, bit hard to re-state them all, but thanks for the links.
Regards.
- Forums
- ASX - By Stock
- ATH
- Forebrain atrophy in early AD, by Masters et al
Forebrain atrophy in early AD, by Masters et al, page-20
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.98M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $405 | 101.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 67728290 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 28660598 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 67728290 | 0.004 |
51 | 48475564 | 0.003 |
17 | 40589402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 28660598 | 22 |
0.006 | 33929757 | 14 |
0.007 | 15220649 | 13 |
0.008 | 14174718 | 13 |
0.009 | 6000000 | 5 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online